Judith W. M. Jeuken

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas

Christian Hartmann, Jochen Meyer, David Capper et al. · Acta Neuropathologica · 2009 · 1.1K citations

Neuro-oncology, Somatic Variant, Diffuse Gliomas +9

<i>MGMT</i> Promoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Study 26951

Martin J. van den Bent, Hendrikus J. Dubbink, Marc Sanson et al. · Journal of Clinical Oncology · 2009 · 253 citations · Full text

The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone

Remco J. Molenaar, Dagmar Verbaan, Simona Lamba et al. · Neuro-Oncology · 2014 · 208 citations · Full text

MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas

Judith W. M. Jeuken, S.J.B. Cornelissen, Martine Vriezen et al. · Laboratory Investigation · 2007 · 179 citations · Full text

Semiquantitative Detection, Neuro-oncology, Glioma +11

Multiplex Ligation-Dependent Probe Amplification

Judith W. M. Jeuken, S.J.B. Cornelissen, Sandra Boots‐Sprenger et al. · Journal of Molecular Diagnostics · 2006 · 126 citations · Full text

Bioanalysis, Molecular Biology, Nucleic Acid Amplification Test +2